A comprehensive view of Clinical Trials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Economist: Russia authorizing use of patented inventions from US, 'unfriendly' nations without compensation shows intellectual property is another casualty of war; new law hurts pharmaceutical R&D, as most foreign drugmakers won't launch trials in Russia
Published: June 24, 2022 by The Economist
Labcorp collaborating with HealthVerity to expand Labcorp’s drug development, clinical trial programs; partnership gives Labcorp access to HIPAA-compliant data from HealthVerity’s database of health care, consumer data
Published: June 24, 2022 by ENP Newswire
McKesson and HCA Healthcare form oncology research JV to expand clinical research, accelerate drug development, increase availability and access to clinical trials in underserved communities; McKesson to own 51% of JV, have operating control
Published: June 24, 2022 by Business Wire
Plus Therapeutics partners with Biocept to use Biocept’s CNSide cerebrospinal fluid assay in ReSPECT-LM Phase 1/2a clinical trial of injectable Rhenium-186 nanoLiposome to treat leptomeningeal metastases, a cancer of brain, spinal cord membranes
Published: June 23, 2022 by GlobeNewswire
Eli Lilly supplying Aveo Oncology with Erbitux cetuximab for North American clinical trial evaluating Aveo’s ficlatuzumab with cetuximab to treat metastatic head, neck squamous cell carcinoma; Merck KGaA providing cetuximab outside of US, Canada
Published: June 23, 2022 by GlobeNewswire

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count